{"id":"https://openalex.org/W2622264342","doi":"https://doi.org/10.1161/str.47.suppl_1.wp303","title":"Abstract WP303: Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The ATRIA Study","display_name":"Abstract WP303: Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The ATRIA Study","publication_year":2016,"publication_date":"2016-02-01","ids":{"openalex":"https://openalex.org/W2622264342","doi":"https://doi.org/10.1161/str.47.suppl_1.wp303","mag":"2622264342"},"language":"en","primary_location":{"id":"doi:10.1161/str.47.suppl_1.wp303","doi":"https://doi.org/10.1161/str.47.suppl_1.wp303","is_oa":false,"landing_page_url":"https://doi.org/10.1161/str.47.suppl_1.wp303","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014358235","display_name":"Liane O. Dallalzadeh","orcid":"https://orcid.org/0000-0001-6179-8747","observed_orcids":["https://orcid.org/0000-0001-6179-8747"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liane O Dallalzadeh","raw_affiliation_strings":["Div of General Internal Medicine, Harvard Med Sch, Boston, MA","Liane O Dallalzadeh"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div of General Internal Medicine, Harvard Med Sch, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Liane O Dallalzadeh","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026846209","display_name":"Alan S. Go","orcid":"https://orcid.org/0000-0001-9109-0811","observed_orcids":["https://orcid.org/0000-0001-9109-0811","https://orcid.org/0000-0001-5671-0763"]},"institutions":[{"id":"https://openalex.org/I4405284138","display_name":"Kaiser Permanente Northern California","ror":"https://ror.org/0302f6d89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4405284138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan S Go","raw_affiliation_strings":["Div of Rsch, Kaiser Permanente Northern California, San Francisco, CA","Alan S Go"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div of Rsch, Kaiser Permanente Northern California, San Francisco, CA","institution_ids":["https://openalex.org/I4405284138"]},{"raw_affiliation_string":"Alan S Go","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050981927","display_name":"Yuchiao Chang","orcid":"https://orcid.org/0000-0003-1093-3755","observed_orcids":["https://orcid.org/0000-0003-1093-3755"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuchiao Chang","raw_affiliation_strings":["Div of General Internal Medicine, Massachusetts General Hosp, Boston, MA","Yuchiao Chang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div of General Internal Medicine, Massachusetts General Hosp, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Yuchiao Chang","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024099354","display_name":"Leila H. Borowsky","orcid":"https://orcid.org/0000-0001-7498-4450","observed_orcids":["https://orcid.org/0000-0001-7498-4450"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leila H Borowsky","raw_affiliation_strings":["Div of General Internal Medicine, Massachusetts General Hosp, Boston, MA","Leila H Borowsky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div of General Internal Medicine, Massachusetts General Hosp, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Leila H Borowsky","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055666587","display_name":"Margaret C. Fang","orcid":"https://orcid.org/0000-0003-3362-1543","observed_orcids":["https://orcid.org/0000-0003-3362-1543"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret C Fang","raw_affiliation_strings":["Dept of Medicine, Univ of California, San Francisco, San Francisco, CA","Margaret C Fang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Medicine, Univ of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Margaret C Fang","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020290782","display_name":"Daniel E. Singer","orcid":"https://orcid.org/0000-0001-6145-4848","observed_orcids":["https://orcid.org/0000-0001-6145-4848"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E Singer","raw_affiliation_strings":["General Internal Medicine, Massachusetts General Hosp, Boston, MA","Daniel E Singer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Internal Medicine, Massachusetts General Hosp, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Daniel E Singer","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"47","issue":"suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.875},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/time-in-therapeutic-range","display_name":"time in therapeutic range","score":0.8619999885559082},{"id":"https://openalex.org/keywords/anticoagulation-stability","display_name":"anticoagulation stability","score":0.9369999766349792},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.847000002861023},{"id":"https://openalex.org/keywords/anticoagulant-switching","display_name":"anticoagulant switching","score":0.6460000276565552},{"id":"https://openalex.org/keywords/inr-monitoring","display_name":"INR monitoring","score":0.6759999990463257},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8289999961853027},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.5649999976158142},{"id":"https://openalex.org/keywords/community-based-care","display_name":"community-based care","score":0.5899999737739563},{"id":"https://openalex.org/keywords/anticoagulation-clinic","display_name":"anticoagulation clinic","score":0.8040000200271606},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9604223370552063},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8900597095489502},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8054299354553223},{"id":"https://openalex.org/C2776259030","wikidata":"https://www.wikidata.org/wiki/Q769508","display_name":"Bleed","level":2,"score":0.5948208570480347},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5892224907875061},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5882450342178345},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5689274072647095},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.48268961906433105},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4455476701259613},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31966477632522583},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/str.47.suppl_1.wp303","doi":"https://doi.org/10.1161/str.47.suppl_1.wp303","is_oa":false,"landing_page_url":"https://doi.org/10.1161/str.47.suppl_1.wp303","pdf_url":null,"source":{"id":"https://openalex.org/S62532593","display_name":"Stroke","issn_l":"0039-2499","issn":["0039-2499","1524-4628"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stroke","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2481806385","https://openalex.org/W2061447560","https://openalex.org/W3047508295","https://openalex.org/W2596716608","https://openalex.org/W2741886718","https://openalex.org/W2432509778","https://openalex.org/W2071851588","https://openalex.org/W2145232618","https://openalex.org/W2267668935","https://openalex.org/W2260426164"],"abstract_inverted_index":{"Introduction:":[0],"Warfarin":[1,49],"reduces":[2],"stroke":[3],"risk":[4],"in":[5,24,54,94,114],"atrial":[6],"fibrillation":[7],"(AF),":[8],"but":[9,47],"increases":[10],"bleed":[11],"risk.":[12],"Frequent":[13],"testing":[14],"with":[15,72,97,159,190,197,231,270],"dose":[16],"adjustment":[17],"is":[18,59,67],"needed":[19],"to":[20,83,85,153,251,278],"maintain":[21,123,240],"INR":[22],"levels":[23],"the":[25,81,115,129,170,244],"therapeutic":[26,55],"range":[27,56],"of":[28,91,119,133,172,182,228],"2.0-3.0.":[29],"Novel":[30],"anticoagulants":[31],"(NOACs)":[32],"now":[33],"challenge":[34],"warfarin":[35,92,120,140,144,238,274],"as":[36,64],"stroke-preventive":[37],"therapy":[38,121,145],"for":[39,267],"AF.":[40],"They":[41],"are":[42],"available":[43],"at":[44,51],"fixed":[45],"doses":[46],"costlier.":[48],"anticoagulation":[50,93,105,275],"a":[52,86,279],"time":[53],"(TTR)":[57],"\u226570%":[58,74,101,113,163,199,242],"similarly":[60],"effective":[61],"and":[62,79,176,214],"safe":[63],"NOACs.":[65],"It":[66],"unclear":[68],"whether":[69],"AF":[70,95,108,134,229,268],"patients":[71,96,109,158,189,230,269],"TTR":[73,100,112,125,184,236,241],"will":[75,122,239],"remain":[76],"stably":[77],"anticoagulated":[78],"avoid":[80],"need":[82],"switch":[84],"NOAC.":[87,280],"We":[88,149],"assessed":[89],"stability":[90],"an":[98],"initial":[99,206,234,271],"primarily":[102],"managed":[103],"by":[104,165],"clinics.":[106],"Hypothesis:":[107],"who":[110,142],"achieve":[111,154],"first":[116],"6":[117,246],"months":[118,151],"high":[124,232,272],"subsequently.":[126],"Methods:":[127],"Within":[128],"community-based":[130],"ATRIA":[131],"cohort":[132],"patients,":[135],"we":[136,168],"identified":[137],"2521":[138],"new":[139],"users":[141],"continued":[143],"over":[146,243],"15":[147],"months.":[148,247],"excluded":[150],"1-3":[152],"stable":[155],"dose.":[156],"For":[157],"TTR1":[160,191,207],"(months":[161,174],"4-9)":[162],"(TTR":[164],"Rosendaal":[166],"method),":[167],"describe":[169],"distribution":[171],"TTR2":[173,198,223],"10-15)":[175],"assess":[177],"multivariable":[178],"(logistic":[179],"regression)":[180],"correlates":[181],"persistent":[183],"\u226570%.":[185,224],"Results:":[186],"Of":[187,201],"1074":[188],"\u226570%,":[192],"57%":[193],"(95%CI:":[194],"53-61%)":[195],"persisted":[196],"(Figure).":[200],"multiple":[202],"patient":[203],"features,":[204],"only":[205],"\u226590%,":[208],"aOR":[209],"[95%":[210],"CI]:":[211],"1.43":[212],"[1.05,1.93]);":[213],"heart":[215],"failure":[216],"aOR:":[217],"0.78":[218],"[0.57,":[219],"1.06])":[220],"independently":[221],"predicted":[222],"Conclusions:":[225],"Nearly":[226],"60%":[227],"quality":[233,273],"6-month":[235],"on":[237],"next":[245],"A":[248],"minority":[249],"deteriorate":[250],"very":[252],"poor":[253],"TTR.":[254],"Patient":[255],"features":[256],"do":[257],"not":[258],"strongly":[259],"predict":[260],"deterioration.":[261],"Our":[262],"analyses":[263],"support":[264],"watchful":[265],"waiting":[266],"before":[276],"switching":[277]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-06-15T00:00:00"}